MedPath

Pregnancy and Use of Psychoactive Substances: The Influence of Representations of Care on Care.

Not Applicable
Completed
Conditions
Pregnancy
Interventions
Other: qualitative study based on an individual clinical interview
Registration Number
NCT03567070
Lead Sponsor
University Hospital, Caen
Brief Summary

It is observed that pregnant women using psychoactive substance (s) have a more random and more accidental pregnancy follow-up than women with no addictive problems.

The consumption approach can be either omitted during the pregnancy monitoring, or entrusted to the course or more often in late pregnancy or occurs more brutally during delivery at the time of complications (neonatal or obstetric). In this context, health professionals are looking for levers that allow women to take appropriate care quickly.

This difficulty of access to care questions us and all the more because the time of the pregnancy is a moment of important psychic reorganization conducive to modify its habits, to change its glance on its consumptions and thus to start a care concerning addiction.

Invesigators hypothesize that this population has less access to medical care during pregnancy for fear of stigmatization by the health care provider.

Invesigators propose a multicenter qualitative study based on individual clinical interviews to collect the testimony of women who used psychoactive substance (s) during their pregnancy.

The purpose of this work is to identify ways to improve the multidisciplinary medical management of these women by focusing on the representations they can make care of.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
9
Inclusion Criteria
  • Major patients
  • Pregnant or having given birth since <28 days
  • Having used (whether declared or discovered incidentally) - regardless of the amount of psychoactive substance (s) during pregnancy: alcohol, and / or heroin or OST, and / or cannabis, and / or psychostimulants (cocaine, ecstasy, amphetamines)
  • Followed or not in addictology during pregnancy
Exclusion Criteria
  • Minor patients
  • Patients under legal protection (guardianship, guardianship)
  • Linguistic obstacle
  • Psychiatric pathology decompensated at the time of the meeting
  • Women who only used tobacco regularly during pregnancy
  • Women who have only regularly used psychoactive drugs and / or licit opiates (excluding prescription replacement products) during pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
qualitative study based on an individual clinical interviewqualitative study based on an individual clinical interview-
Primary Outcome Measures
NameTimeMethod
individual clinical interviewbaseline

qualitative study based on an individual clinical interview

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Caen University Hospital

🇫🇷

Caen, France

© Copyright 2025. All Rights Reserved by MedPath